LoginRegister

    Zydus gets USFDA final approval for Valacyclovir tablets

    Written by Ruby Khatun Khatun   |  
    Zydus gets USFDA final approval for Valacyclovir tablets

    Ahmedabad: Zydus Pharmaceuticals USA Inc has received the final approval from the USFDA to market Valacyclovir Tablets USP in strengths of 500 mg and 1 gm.


    The drug is indicated for the treatment of cold sores (herpes labialis), genital herpes, chickenpox and herpes zoster (shingles).


    It will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad.


    The group now has more than 180 approvals and has so far filed over 310 ANDAs since the commencement of the filing process in FY 2003-04.


    Zydus Pharmaceuticals Inc is a wholly-owned subsidiary of Cadila Healthcare Ltd.

    AhmedabadCadila Healthcare Ltdchickenpoxcold soresdrugfinal approvalgenital herpesherpes labialisHerpes Zosterindian pharma newsMoraiyapharma newspharma news indiashinglestreatmentUSFDAValacyclovir tabletszydusZydus CadilaZydus PharmaceuticalsZydus Pharmaceuticals USA Inc
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X